Advisor Group Holdings, Inc. Novan, Inc. Transaction History

Advisor Group Holdings, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$1.76 - $3.03 $3,277 - $5,641	1,862 Added 3724.0%	1,912 $4,000
Q3 2021 Nov 05, 2021	SELL	$7.48 - $10.17 $748 - $1,017	-100 Reduced 66.67%	50 $0
Q2 2021 Aug 02, 2021	BUY	$7.8 - $17.35 $1,170 - $2,602	150 New	150 $2,000

Ticker NOVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,281,600
Market Cap $638K
Description
Novan, Inc., a pre-commercial nitric oxide-based pharmaceutical company, focuses on dermatology and anti-infective therapies. Its clinical stage dermatology drug candidates include SB204, a topical monotherapy for the treatment of acne vulgaris; SB206, a topical anti-viral gel for the treatment of viral skin infections; SB208, a topical broad-sp...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.